Publications
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor
Swiecicki, PL,
Bellile, E,
Casper, K,
Chinn, SB,
Dragovic, AF,
Jolly, S,
Kupfer, R,
Malloy, KM,
Mierzwa, ML,
Shuman, AG,
Spector, ME,
Srinivasan, A,
Stucken, C,
Bradford, CR,
Eisbruch, A,
Carey, TE,
Prince, ME,
Wolf, GT,
Worden, FP,
Head Neck, 2022 Jul; DOI:10.1002/hed.27043 HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis
Singal, AG,
Zhang, E,
Narasimman, M,
Rich, NE,
Waljee, AK,
Hoshida, Y,
Yang, JD,
Reig, M,
Cabibbo, G,
Nahon, P,
Parikh, ND,
Marrero, JA,
J Hepatol, 2022 Jul; DOI:10.1016/j.jhep.2022.01.023 Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.
Buschhaus, JM,
Rajendran, S,
Humphries, BA,
Cutter, AC,
Muñiz, AJ,
Ciavattone, NG,
Buschhaus, AM,
Cañeque, T,
Nwosu, ZC,
Sahoo, D,
Bevoor, AS,
Shah, YM,
Lyssiotis, CA,
Ghosh, P,
Wicha, MS,
Rodriguez, R,
Luker, GD,
Oncogene, 2022 Jul; DOI:10.1038/s41388-022-02385-9 The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.
Vo, JN,
Wu, Y-M,
Mishler, J,
Hall, S,
Mannan, R,
Wang, L,
Ning, Y,
Zhou, J,
Hopkins, AC,
Estill, JC,
Chan, WKB,
Yesil, J,
Cao, X,
Rao, A,
Tsodikov, A,
Talpaz, M,
Cole, CE,
Ye, JC,
Multiple Myeloma Research Consortium, Array,
Bergsagel, PL,
Auclair, D,
Cho, HJ,
Robinson, DR,
Chinnaiyan, AM,
Nat Commun, 2022 Jun; DOI:10.1038/s41467-022-31430-0 US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study
Harper, DM,
Plegue, M,
Jimbo, M,
Sheinfeld Gorin, S,
Sen, A,
Elife, 2022 Jun; DOI:10.7554/eLife.76070 The dual interaction of antimicrobial peptides on bacteria and cancer cells; mechanism of action and therapeutic strategies of nanostructures
Parchebafi, A,
Tamanaee, F,
Ehteram, H,
Ahmad, E,
Nikzad, H,
Haddad Kashani, H,
Microb Cell Fact, 2022 Jun; DOI:10.1186/s12934-022-01848-8 MyProstateScore in Men Considering Repeat Biopsy: Validation of a Simple Testing Approach
Tosoian, J,
Sessine, M,
Trock, B,
Ross, A,
Xie, C,
Zheng, Y,
Samora, N,
Siddiqui, J,
Niknafs, Y,
Chopra, Z,
Tomlins, S,
Kunju, L,
Palapattu, G,
Morgan, T,
Wei, J,
Salami, S,
Chinnaiyan, A,
2022 Jun; DOI:10.21203/rs.3.rs-1728404/v1 Abstract 3649: Stromal netrinG1-ligand (NGL1) constitutes a new modulator of pancreatic cancer immunosuppression
Vendramini-Costa, DB,
Francescone, R,
Franco-Barraza, J,
Luong, T,
Martinez, E,
Sykes, S,
Steele, NG,
Allen, BL,
Pasca di Magliano, M,
Zhigarev, DI,
Ogier, C,
Astsaturov, I,
Cai, KQ,
Klein-Szanto, AJ,
Wang, H,
Campbell, K,
Cukierman, E,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3649 A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers
Tayob, N,
Lok, ASF,
Feng, Z,
Stat Med, 2022 Jun; DOI:10.1002/sim.9358 Abstract 3936: Orally bioavailable 'lymphatropic' kinase inhibitors
Ross, BD,
Jang, Y,
Welton, A,
Bonham, CA,
Heist, K,
McDonald, L,
Luker, GD,
Chenevert, TL,
Van Dort, M,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3936 Abstract 5741: Characterizing isoform switching events in esophageal adenocarcinoma
Zhang, Y,
Weh, KM,
Howard, CL,
Riethoven, J-J,
Clarke, JL,
Lagisetty, KH,
Lin, J,
Reddy, RM,
Chang, AC,
Beer, DG,
Kresty, LA,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-5741 Abstract 2966: The epigenetic reader function of the YEATS domain in MLL-ENL fusion critically affects leukemic stem cell frequency in MLL-ENL leukemia
Hu, H,
Saha, N,
Ahmad, E,
Yang, Y,
Chen, L,
Lachowski, L,
Teahan, B,
Grigsby, S,
Marschalek, R,
Nikolovska-Coleska, Z,
Muntean, AG,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-2966 Abstract LB013: Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma
Al-Holou, WN,
Wang, H,
Ravikumar, V,
Oneka, M,
Verhaak, RG,
Kim, H,
Pratt, D,
Camelo-Piragua, S,
Speers, C,
Wahl, D,
Shankar, S,
Hollon, T,
Sagher, O,
Heth, J,
Muraszko, KM,
Lawrence, TS,
deCarvalho, AC,
Mikkelsen, T,
Rao, A,
Rehemtulla, A,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-lb013 Abstract 6366: A novel small molecule inhibitor of MAPK and PI3K ameliorates disease phenotypes in myelofibrosis
Bonham, CA,
Jang, Y,
Heist, K,
Welton, A,
Robison, T,
Luker, KE,
Luker, GD,
Lee, WY,
Chenevert, TL,
Van Dort, M,
Ross, BD,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-6366 Therapeutic benefit of dual ALK and FAK inhibition in neuroblastoma
Chugh, S,
Tien, JC,
Hon, J,
Bawa, PS,
Kenum, C,
Li, CC,
Cheng, Y,
Delekta, AD,
Choi, JE,
Mannan, R,
Qiao, Y,
Mody, R,
Chinnaiyan, A,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-2018 Abstract 3383: Circular RNAs as non-invasive diagnostic biomarkers for prostate cancer
Shah, P,
Bawa, P,
Xiao, L,
Kleyman, Y,
Vo, J,
Dhanasekaran, SM,
Brown, J,
Loeding, N,
Koons, A,
Siddiqui, J,
Cao, X,
Chinnaiyan, AM,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3383 Abstract 5274: Mechanisms of action (MOA) for proxalutamide, an androgen receptor (AR) antagonist, for the treatment of mild, moderate and severe COVID-19 patients
Ma, L,
Tong, Y,
Zhou, Q,
Yan, H,
Hou, X,
Ren, Z,
Li, J,
Wang, H,
Qian, W,
Zhang, Y,
Goren, A,
Chinnaiyan, A,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-5274 Abstract 3072: Functional assays of drug sensitivity in real-time from patient material for precision oncology in bladder cancer
Merrill, NM,
Bao, L,
Cheng, X,
Vandecan, N,
Qin, Z,
Liu, A,
Apfel, A,
Goo, L,
Tudrick, L,
Bankhead, A,
Palmbos, P,
Kaffenberger, S,
Hafez, K,
Montgomery, J,
Morgan, T,
Alva, A,
Udager, A,
Soellner, M,
Merajver, S,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3072 Small molecule mediated stabilization of PP2A modulates the homologous recombination pathway and potentiates DNA damage-induced cell death
Avelar, RA,
Armstrong, A,
Narla, G,
DiFeo, A,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3340 Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Xiao, L,
Parolia, A,
Qiao, Y,
Pushpinder, PB,
Eyunni, S,
Mannan, R,
Carson, SE,
Chang, Y,
Wang, X,
Zhang, Y,
Vo, J,
Kregel, S,
Simko, SA,
Delekta, AD,
Jaber, M,
Zheng, H,
Apel, I,
McMurry, L,
Su, F,
Wang, R,
Wang, S,
Sasmal, S,
Satyam, LK,
Mukherjee, S,
AbbinenI, C,
Aithal, K,
Bhakta, MS,
Ghurye, J,
Cao, X,
Navone, NM,
Nesvizhskii, A,
Mehra, R,
Vaishampayan, U,
Blanchette, M,
Wang, Y,
Samajdar, S,
Ramachandra, M,
Chinnaiyan, AM,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-5469 Targeting SWI/SNF ATPases in enhancer-addicted human cancers
Parolia, A,
Xiao, L,
Qiao, Y,
Bawa, P,
Eyunni, S,
Young, E,
Mannan, R,
Carson, SE,
Chang, Y,
Zhang, Y,
George, J,
Jaber, M,
Su, F,
Wang, R,
Sasmal, S,
Khare, L,
Mukerjee, S,
AbbinenI, C,
Aithal, K,
Cao, X,
Wang, Y,
Samajdar, S,
Ramachandra, M,
Chinnaiyan, AM,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-3592 Identification of a targeted anti-mitotic agent that degrades Myc and specifically induces cancer cell death
McAnulty, J,
Dziubinski, M,
Gandhi, A,
Farah, M,
Lee, P,
White, AD,
DiFeo, A,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-4003 Abstract 2538: Role of Argonaute 2 in regulation of immune microenvironment in pancreatic cancer
Hon, J,
Kenum, C,
Bawa, PS,
Dommeti, VL,
Sahu, AA,
Gandham, M,
Li, C-C,
Taher, ZI,
Zelenka-Wang, S,
Tien, JC,
Shankar, S,
Chugh, S,
Chinnaiyan, AM,
Cancer Research, 2022 Jun; DOI:10.1158/1538-7445.am2022-2538 Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
Deng, Q,
Natesan, R,
Cidre-Aranaz, F,
Arif, S,
Liu, Y,
Rasool, RU,
Wang, P,
Mitchell-Velasquez, E,
Das, CK,
Vinca, E,
Cramer, Z,
Grohar, PJ,
Chou, M,
Kumar-Sinha, C,
Weber, K,
Eisinger-Mathason, TSK,
Grillet, N,
Grünewald, TGP,
Asangani, IA,
Cell Rep, 2022 Jun; DOI:10.1016/j.celrep.2022.110971 EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).
Ryan, CW,
Tangen, C,
Heath, EI,
Stein, MN,
Meng, M,
Alva, AS,
Pal, SK,
Puzanov, I,
Clark, JI,
Choueiri, TK,
Agarwal, N,
Uzzo, R,
Haas, NB,
Synold, TW,
Plets, M,
Vaishampayan, UN,
Shuch, BM,
Vogelzang, NJ,
Thompson, IM,
Lara, PLN,
Journal of Clinical Oncology, 2022 Jun; DOI:10.1200/jco.2022.40.17_suppl.lba4500 